SHIM
VYGR icon

Stone House Investment Management’s Voyager Therapeutics VYGR Stock Holding History

Stone House Investment Management’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$917 Buy
262
+175
+201% +$664 ﹤0.01% 899
2026
Q1 		$336 Buy
+87
New +$343 ﹤0.01% 875

Other funds holding VYGR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Stone House Investment Management's VYGR Position: Q2 2026 in Review

Stone House Investment Management increased its Voyager Therapeutics (VYGR) stake by 201% in Q2 2026, buying an estimated $664 and bringing the position to 262 shares worth $917. The position accounts for ﹤0.01% of the portfolio, ranked #899.

Stone House Investment Management first reported a position in VYGR in Q1 2026 and has held it in 2 quarters since. 136 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

  • Stone House Investment Management held 262 shares of Voyager Therapeutics worth $917 as of Q2 2026.
  • Stone House Investment Management bought 175 Voyager Therapeutics shares in Q2 2026, an estimated $664.
  • Voyager Therapeutics made up ﹤0.01% of Stone House Investment Management's portfolio in Q2 2026, its #899 holding.
  • Stone House Investment Management first reported a position in Voyager Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 136 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on Stone House Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.